An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes
Condition(s):HypertensionLast Updated:November 3, 2016Completed
Hide Studies Not Open or Pending
Condition(s):HypertensionLast Updated:November 3, 2016Completed
Condition(s):HypertensionLast Updated:March 3, 2009Unknown status
Condition(s):Essential HypertensionLast Updated:February 7, 2012Completed
Condition(s):Overweight; Obese; Prehypertension; HypertensionLast Updated:January 3, 2018Completed
Condition(s):Stroke, IschemicLast Updated:January 7, 2020Completed
Condition(s):Peripheral Artery Disease With Intermittent ClaudicationLast Updated:January 28, 2019Terminated
Condition(s):Essential HypertensionLast Updated:July 23, 2009Completed
Condition(s):Essential Hypertension; Renal ImpairmentLast Updated:October 14, 2010Completed
Condition(s):Essential HypertensionLast Updated:January 9, 2019Completed
Condition(s):HypertensionLast Updated:September 16, 2005Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.